The hazards of exposure to 4-nitrobiphenyl (2395995) (NBP) are reviewed. Incidences of bladder cancer in 11.1 percent of workers are cited as part of an epidemiological study of workers involved in the production of 4-aminodiphenyl (92671) (ADP), which was produced from 1935 to 1955 in the United States. The carcinogenicity of both compounds is stressed, and both are noted as probably responsible for the tumors reported in workers. A study is reported for administration of NBP 3 times weekly in four dogs, three of which developed malignant bladder tumors. The conclusion is cited that based on experiments in dogs, NBP is as potent a carcinogen as ADP. Other experiments in dogs are discussed in which lower doses of NBP or doses in combination with 2-napthylamine (91598) (NA) are given. The relative carcinogenic potency of ADP, NA, NBP, and benzidine (92875) are given as 1, 6, 17, and 27, respectively. Evidence is presented for in-vivo reduction of NBP to ADP and 4-amino-3-biphenyl- hydrogen-sulfate. The author concludes that the case for carcinogenicity of NBP is supported by the induction of bladder carcinoma in dogs, the evidence that NBP is metabolized to ADP, and the possibility that human cases of bladder cancer may have been induced by exposure to NBP as well as to ADP.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.